Kaléo Inc. Agrees

VA 2026 Independent Pharmacies

OIG False Claims Controlled Substance

Penalty

$12.7 million

Outcome

OIG enforcement action against Kaléo Inc. Agrees for false claims, controlled substance. Penalty: $12.7 million.

Details

Kaléo Inc. Agrees — OIG Enforcement (2026)

OIG took enforcement action against Kaléo Inc. Agrees in VA in 2026 involving false claims, controlled substance violations in the Independent Pharmacies sector.

Penalty: $12.7 million

Violation types: False Claims, Controlled Substance
Entity type: Pharmacy
Penalty type: Settlement
Location: VA

Source: Kaléo Inc. Agrees to Pay $12.7 Million to Resolve Allegations of False Claims for Anti-Overdose Drug

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: Kaléo Inc. Agrees to Pay $12.7 Million to Resolve Allegations of False Claims for Anti-Overdose Drug

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works